Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals
Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals have?
Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals has 13 citations in the OpenAlex counts ScholarIQ stores.
When was Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals published?
Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals has 2022 year in the ScholarIQ index.
What is the open-access status of Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals?
Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals has gold oa status in the ScholarIQ index.
What is the DOI of Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals?
The DOI for Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals is on the source record.
What is the PMID of Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals?
The PMID for Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals is on the source record.
What is the OpenAlex record for Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals?
The OpenAlex for Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals is on the source record.